Application prospect of blood-based biomarker p-tau217 in Alzheimer disease
Bai Li
Hu Weihong
Abstract：Alzheimer disease(AD)is a common form of elderly dementia that currently lacks effective treatment.Therefore,early diagnosis and intervention are particularly important.Currently,peripheral biomarkers are becoming a research hotspot in AD.Recent studies have shown that plasma p-tau217 plays an important role in the early diagnosis,differentiation,treatment monitoring,and prognosis evaluation of AD,and has good application prospects.However,further standardization of laboratory protocols and optimal cut-off values need to be determined.This paper reviews the above progress,aiming to provide a basis for clinical applications.
Keywords：Alzheimer diseasePlasma biomarkerp-tau217Review
Publication Date：2023-11-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 807-813 )